Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meriem Hasmim

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Autophagy|February 26, 2015
The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killingYosra Messai, Muhammad Zaeem Noman, Bassam Janji, et al.
Autophagy|September 7, 2020
Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34Bassam Janji, Meriem Hasmim, Santiago Parpal, et al.
American Journal of Physiology. Cell Physiology|August 28, 2015
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaMuhammad Zaeem Noman, Meriem Hasmim, Yosra Messai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1Meriem Hasmim, Muhammad Zaeem Noman, Yosra Messai, et al.
Autophagy|May 3, 2013
EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy inductionIntissar Akalay, Bassam Janji, Meriem Hasmim, et al.
Frontiers in Immunology|October 7, 2015
Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressMeriem Hasmim, Yosra Messai, Linda Ziani, et al.
Critical Reviews in Immunology|December 7, 2011
Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor responseMuhammad Zaeem Noman, Yosra Messai, Thibault Carré, et al.
Cells|September 22, 2019
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and ChallengesMuhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
The Journal of Experimental Medicine|April 30, 2014
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activationMuhammad Zaeem Noman, Giacomo Desantis, Bassam Janji, et al.
Frontiers in Oncology|March 15, 2021
Targeting Cytoprotective Autophagy to Enhance Anticancer TherapiesMalina Xiao, Alice Benoit, Meriem Hasmim, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Autophagy|February 26, 2015
The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killingYosra Messai, Muhammad Zaeem Noman, Bassam Janji, et al.
Autophagy|September 7, 2020
Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34Bassam Janji, Meriem Hasmim, Santiago Parpal, et al.
American Journal of Physiology. Cell Physiology|August 28, 2015
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaMuhammad Zaeem Noman, Meriem Hasmim, Yosra Messai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1Meriem Hasmim, Muhammad Zaeem Noman, Yosra Messai, et al.
Autophagy|May 3, 2013
EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy inductionIntissar Akalay, Bassam Janji, Meriem Hasmim, et al.
Frontiers in Immunology|October 7, 2015
Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressMeriem Hasmim, Yosra Messai, Linda Ziani, et al.
Critical Reviews in Immunology|December 7, 2011
Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor responseMuhammad Zaeem Noman, Yosra Messai, Thibault Carré, et al.
Cells|September 22, 2019
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and ChallengesMuhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux, et al.
The Journal of Experimental Medicine|April 30, 2014
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activationMuhammad Zaeem Noman, Giacomo Desantis, Bassam Janji, et al.
Frontiers in Oncology|March 15, 2021
Targeting Cytoprotective Autophagy to Enhance Anticancer TherapiesMalina Xiao, Alice Benoit, Meriem Hasmim, et al.
Pageof 5